PELVIC FIBROSIS

This adverse event was reported 6 times

PELVIC FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MITOMYCIN 1 0.0003
1 PYRIDOSTIGMINE BROMIDE 1 0.0001
2 FLUOROURACIL CREAM, 0.5% 1 0.0000
3 FLUOROURACIL 1 0.0000
4 CISPLATIN 1 0.0000
5 BEVACIZUMAB 1 0.0000
6 CARBOPLATIN 1 0.0000
7 MYCOPHENOLATE MOFETIL 1 0.0000
8 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
9 LEVONORGESTREL 1 0.0000
See all drugs enriched for association with PELVIC FIBROSIS

PELVIC FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
1 Alkylating Drug [EPC] 1 0.0000
2 Platinum-based Drug [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
4 Progestin [EPC] 1 0.0000
5 Proton Pump Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with PELVIC FIBROSIS